# Black Diamond Therapeutics, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/black-diamond-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 15 |
| Claims under review | 1 |
| Evidence records | 3 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-17T04:46:51.162298+00:00 |
| Last reviewed | 2026-10-17T04:46:51.162298+00:00 |

## Identity

- Legal name: Black Diamond Therapeutics, Inc.
- Display name: Black Diamond Therapeutics, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-17T08:08:49.245372+00:00 |
| Completeness | 0.364 |
| Record Quality | 0.83 |
| Directors | 7 |
| Committees | 1 |
| Governance events | 8 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | NOT_REVIEWED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Ali Behbahani, M.D.: Director. Status: current. Independent: true. Since: 2018-01-01. claim_id=alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:leadership_role:7
- Garry E. Menzel, Ph.D.: Director. Status: current. Independent: true. Since: 2017-01-01. claim_id=alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:leadership_role:8
- Kapil Dhingra, M.B.B.S.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:leadership_role:9
- Mark A. Velleca, M.D., Ph.D.: Director. Status: current. Independent: false. Since: 2021-01-01. claim_id=alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:leadership_role:10
- Prakash Raman, Ph.D.: Director. Status: current. Independent: true. Since: 2024-01-01. claim_id=alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:leadership_role:11
- Samarth Kulkarni, Ph.D.: Director. Status: current. Independent: true. Since: 2019-01-01. claim_id=alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:leadership_role:12
- Shannon Campbell: Director. Status: current. Independent: true. Since: 2022-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:leadership_role:13

## Committees

- Compensation (compensation). Chair: NOT_PUBLISHED. Members: Shannon Campbell (member, current). committee_id=alpha:committee:black-diamond-therapeutics-inc:compensation

## Governance events

- DIRECTOR_APPOINTED: Prakash Raman, Ph.D. seat on Black Diamond Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:1pow0cc1j7262u
- DIRECTOR_APPOINTED: Shannon Campbell seat on Black Diamond Therapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:10veqikompzj6
- COMMITTEE_MEMBER_ADDED: Shannon Campbell member of Compensation, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:os9ligz4zx44
- DIRECTOR_APPOINTED: Kapil Dhingra, M.B.B.S. seat on Black Diamond Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:3p5a8w1e3qgwq
- DIRECTOR_APPOINTED: Mark A. Velleca, M.D., Ph.D. seat on Black Diamond Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:hpwah61vx98gm
- DIRECTOR_APPOINTED: Samarth Kulkarni, Ph.D. seat on Black Diamond Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:1gsf1gt11k2aj
- DIRECTOR_APPOINTED: Ali Behbahani, M.D. seat on Black Diamond Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:1nqsv9k1ehek12
- DIRECTOR_APPOINTED: Garry E. Menzel, Ph.D. seat on Black Diamond Therapeutics, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:1bida0e1n1gtiq

## Scoped resources

- `alpha://company/black-diamond-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record
- `alpha://company/black-diamond-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=identity
- `alpha://company/black-diamond-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=corporate-structure
- `alpha://company/black-diamond-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=board
- `alpha://company/black-diamond-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=committees
- `alpha://company/black-diamond-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=leadership
- `alpha://company/black-diamond-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=ownership
- `alpha://company/black-diamond-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=financials
- `alpha://company/black-diamond-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=capital-structure
- `alpha://company/black-diamond-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=compensation
- `alpha://company/black-diamond-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=governance
- `alpha://company/black-diamond-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=shareholder-governance
- `alpha://company/black-diamond-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=audit
- `alpha://company/black-diamond-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=legal
- `alpha://company/black-diamond-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=risk
- `alpha://company/black-diamond-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=cyber
- `alpha://company/black-diamond-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=ai-governance
- `alpha://company/black-diamond-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=agents
- `alpha://company/black-diamond-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=ecosystem
- `alpha://company/black-diamond-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=events
- `alpha://company/black-diamond-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=relationships
- `alpha://company/black-diamond-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=assessments
- `alpha://company/black-diamond-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- Claim alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:shannon-campbell","name":"Shannon Campbell"},"source_id":"board_seats"}`

## Leadership

- Ali Behbahani, M.D.: Director. Claim: alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:leadership_role:7. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6df17b6d2920decaefdcb2e5afd48e6a44153a00c5a8c60a684e08621302fbe8.
- Garry E. Menzel, Ph.D.: Director. Claim: alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:leadership_role:8. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6df17b6d2920decaefdcb2e5afd48e6a44153a00c5a8c60a684e08621302fbe8.
- Kapil Dhingra, M.B.B.S.: Director. Claim: alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6df17b6d2920decaefdcb2e5afd48e6a44153a00c5a8c60a684e08621302fbe8.
- Mark A. Velleca, M.D., Ph.D.: Director. Claim: alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:leadership_role:10. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6df17b6d2920decaefdcb2e5afd48e6a44153a00c5a8c60a684e08621302fbe8.
- Prakash Raman, Ph.D.: Director. Claim: alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:leadership_role:11. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6df17b6d2920decaefdcb2e5afd48e6a44153a00c5a8c60a684e08621302fbe8.
- Samarth Kulkarni, Ph.D.: Director. Claim: alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:leadership_role:12. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6df17b6d2920decaefdcb2e5afd48e6a44153a00c5a8c60a684e08621302fbe8.
- Shannon Campbell: Director, Compensation. Claim: alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:leadership_role:13. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6df17b6d2920decaefdcb2e5afd48e6a44153a00c5a8c60a684e08621302fbe8.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- Compensation: Chair not stated; Members Shannon Campbell. Claim: alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:committee_record:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ac362fb246a7228e5826b5bbddcf091f083597165afc58d2fea0f5ccd9241c1c.

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Black Diamond Therapeutics, Inc.. Claim: alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cedd498ee3410f2073a9174fdc69d4fcd3f5440d5fafbfe7804f77f5a7490a88.

## Entity Status

- Public listing published. Claim: alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cedd498ee3410f2073a9174fdc69d4fcd3f5440d5fafbfe7804f77f5a7490a88.

## Published Fact

- US. Claim: alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cedd498ee3410f2073a9174fdc69d4fcd3f5440d5fafbfe7804f77f5a7490a88.
- Healthcare. Claim: alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cedd498ee3410f2073a9174fdc69d4fcd3f5440d5fafbfe7804f77f5a7490a88.
- Biotechnology. Claim: alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cedd498ee3410f2073a9174fdc69d4fcd3f5440d5fafbfe7804f77f5a7490a88.

## Committee Appointment

- Shannon Campbell: member, Compensation. Claim: alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ac362fb246a7228e5826b5bbddcf091f083597165afc58d2fea0f5ccd9241c1c.

## Security Listing

- BDTX (NASDAQ). Claim: alpha:claim:company:ec96f1da-a1c7-40b7-9eee-0f8ac32f0b45:security_listing:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cedd498ee3410f2073a9174fdc69d4fcd3f5440d5fafbfe7804f77f5a7490a88.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:cedd498ee3410f2073a9174fdc69d4fcd3f5440d5fafbfe7804f77f5a7490a88: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/black-diamond-therapeutics-inc).
- alpha:projection-evidence:document:6df17b6d2920decaefdcb2e5afd48e6a44153a00c5a8c60a684e08621302fbe8: [Black Diamond Therapeutics, Inc. DEF 14A 2025-04-18](https://www.sec.gov/Archives/edgar/data/1701541/000110465925036339/tm252436-4_def14a.htm).
- alpha:projection-evidence:ac362fb246a7228e5826b5bbddcf091f083597165afc58d2fea0f5ccd9241c1c: [Compensation](https://www.sec.gov/Archives/edgar/data/1701541/000110465925036339/tm252436-4_def14a.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/black-diamond-therapeutics-inc)
- [Public Markdown](https://registry.alpha.ac/companies/black-diamond-therapeutics-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/black-diamond-therapeutics-inc?format=jsonld)
- MCP resource: `alpha://companies/black-diamond-therapeutics-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-17T08:08:49.053829+00:00; recorded 2026-10-17T08:08:49.053829+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.